Stay updated on UNR844-Cl Eye Drops in Presbyopia: Clinical Trial
Sign up to get notified when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.

Latest updates to the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page
- Check4 days agoChange DetectedThe NIH transition announcement banner was removed from the page, leaving the 403 error message and the site navigation visible.SummaryDifference1%

- Check11 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the clinical study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA general NIH notice about website changes and the terminology transition appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error screen replacing the study record content. A Home link is shown, indicating restricted access to the study page.SummaryDifference17%

- Check60 days agoChange DetectedThe page now shows a new revision tag (v3.7.0) replacing the previous v3.6.6. This indicates an updated page version with internal changes, not changes to the study data or outcomes.SummaryDifference0.1%

Stay in the know with updates to UNR844-Cl Eye Drops in Presbyopia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNR844-Cl Eye Drops in Presbyopia: Clinical Trial page.